New cell therapy injection shows promise for back pain sufferers

NCT ID NCT03955315

Completed Disease control Sponsor: DiscGenics, Inc. Source: ClinicalTrials.gov ↗

First seen Nov 20, 2025 · Last updated Apr 30, 2026 · Updated 16 times

Summary

This study tested a single injection of disc cells into the spine for people with chronic low back pain from degenerative disc disease. 38 adults with moderate disc damage and long-term pain received either a low or high dose of the cell treatment or a sham injection. The goal was to see if the treatment is safe and can reduce pain and disability over a year.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEGENERATIVE DISC DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Chiba University Hospital

Chuo-ku, Chiba, 260-8670, Japan
Mie University Hospital

Tsu, Mie-ken, 514-8507, Japan
Nagoya university hospital

Shōwaku, Nagoya, 466-8550, Japan
Osaka University Hospital

Suita, Osaka, 565-0871, Japan
Tokai University Hospital

Isehara, Kanagawa, 259-1193, Japan
University of Yamanashi Hospital

Chūō, Yamanashi, 409-3898, Japan

Conditions

Explore the condition pages connected to this study.

DEGENERATIVE DISC DISEASE